SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Michael Burry who wrote (6613)4/7/1999 11:57:00 AM
From: Grommit  Read Replies (4) | Respond to of 78520
 
Try this one.

I will post here again, but I am about to give up on this thread.

This thread seems a little too clubbie for my taste. I posted a few times after checking out your recommendations, offering decent information, I thought. And I posted a few picks of my own asking for input. Are my picks that bad?

1. APCC -- high growth, no debt, almost fairly valued but still a bargain.

2. CKR - I chatted with the company yesterday. They are guiding analysts to 1.75 for this year. (Some had gotten a little extreme, without passing their numbers by the company, the company claims.) The company also claims that the guidance is causing the downgrades. But that guidance is still 20% growth or so. They say that all is wonderful.

quote.yahoo.com



To: Michael Burry who wrote (6613)4/7/1999 4:16:00 PM
From: Freedom Fighter  Respond to of 78520
 
Michael,

>>Just trying to figure out the new paradigm.<<

If you do figure out the new paradigm please let me know. I hear the drug companies are working on a new pill that takes care of that particular chemical imbalance.<G>

WC